WashU study co-author and epidemiologist, Ziyad Al-Aly, MD discusses the “staggeringly high burden” of long COVID in the past two+ years.
The Larry J. Shapiro Director of the Institute for Public Health, William Powderly, MD, was national lead investigator of a clinical trial involving patients with severe COVID who were administered two anti-inflammatory drugs. Read more about the study’s findings.
Institute for Public Health Faculty Scholar Ziyad Al-Aly, MD, is featured in this month’s WashU’s Outlook Magazine about his work on “society’s biggest health issues through vast data analysis”
School of Medicine Clinical Epidemiologist and Faculty Scholar, Ziyad Al-Aly discusses how long COVID can manifest as heart problems.
Finally some good news about long COVID. Ziyad Al-Aly, director of WashU’s Clinical Epidemiology Center says its complicated, but LC symptoms are less common now.